Revascularization Strategies and Outcomes in Elderly Patients With Multivessel Coronary Disease

被引:7
|
作者
Posenau, J. Trevor
Wojdyla, Daniel M.
Shaw, Linda K.
Alexander, Karen P.
Ohman, E. Magnus
Patel, Manesh R.
Smith, Peter K.
Rao, Sunil V.
机构
[1] Washington Univ, Sch Med, Div Cardiovasc, St Louis, MO 63110 USA
[2] Duke Clin Res Inst, Durham, NC USA
[3] Duke Univ, Med Ctr, Div Cardiovasc & Thorac Surg, Durham, NC USA
来源
ANNALS OF THORACIC SURGERY | 2017年 / 104卷 / 01期
关键词
BYPASS SURGERY; INTERVENTION; AGE; STENTS;
D O I
10.1016/j.athoracsur.2016.10.053
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Balancing risks and benefits of revascularization in elderly patients with multivessel coronary artery disease (CAD) is challenging. The appropriate revascularization strategy for elderly patients with multivessel CAD is unclear. Methods. We used the Duke Databank for Cardiovascular Disease to identify patients aged 75 years or more who had multivessel disease and treatment with percutaneous coronary intervention or coronary artery bypass graft surgery (CABG) within 30 days of the index catheterization between October 1, 2003, and June 30, 2013. The primary outcome was a composite of all-cause death, myocardial infarction, and coronary revascularization through latest follow-up. Associations between baremetal stents (BMS), drug-eluting stents (DES), CABG, and outcomes were determined using multivariable Cox proportional hazards modeling, adjusting for potential confounders with CABG as the reference. Comparisons between BMS and DES were done using BMS as the reference. Results. We identified 763 patients who met the criteria (BMS, n = 202; DES, n = 411; CABG, n = 150). The median age was 79 years (interquartile range, 76 to 82), and the median follow-up was 6.28 years. After adjustment, both BMS and DES were associated with a higher risk of the primary outcome. The BMS versus CAB Ghazard ratio was 1.58 (95% confidence interval: 1.15 to 2.19, p = 0.01). The DES versus CABG hazard ratio was 1.45 (95% confidence interval: 1.08 to 1.95, p = 0.01). The adjusted hazard ratio for DES versus BMS (0.92, 95% confidence interval: 0.71 to 1.19, p = 0.51) was not statistically significant. Conclusions. In this single-center analysis of 763 elderly patients with multivessel disease, CABG was associated with the best overall clinical outcomes, but was selected for a minority of patients. An adequately powered, randomized trial should be considered to define the best treatment strategy for this population. (C) 2017 by The Society of Thoracic Surgeons
引用
收藏
页码:107 / 115
页数:9
相关论文
共 50 条
  • [41] Completeness of revascularization in multivessel coronary artery disease
    Sandoval, Yader
    Brilakis, Emmanouil S.
    Garcia, Santiago
    JOURNAL OF THORACIC DISEASE, 2016, 8 (11) : E1493 - E1496
  • [42] Gender differences in management and outcomes among patients with acute coronary syndromes and multivessel disease submitted for percutaneous coronary revascularization
    Cabades, C.
    Diez Gil, J. L.
    Aguar, P.
    Sanmiguel, D.
    Lopez-March, A.
    Marmol, R.
    Guerra, L.
    Girbes, V.
    Ferrando, J.
    Rincon De Arellano, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2010, 12 (0F) : F5 - F5
  • [43] IMPACT OF COMPLETE PERCUTANEOUS CORONARY REVASCULARIZATION ON LONG-TERM OUTCOMES IN ACS PATIENTS WITH MULTIVESSEL CORONARY ARTERY DISEASE
    Yasuda, Kentaro
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1342 - 1342
  • [44] Hybrid revascularization in multivessel coronary artery disease
    Repossini, Alberto
    Tespili, Maurizio
    Saino, Antonio
    Kotelnikov, Igor
    Moggi, Annalisa
    Di Bacco, Lorenzo
    Muneretto, Claudio
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2013, 44 (02) : 288 - 294
  • [45] Hybrid Revascularization for Multivessel Coronary Artery Disease
    Gasior, Mariusz
    Zembala, Michael Oscar
    Tajstra, Mateusz
    Filipiak, Krzysztof
    Gierlotka, Marek
    Hrapkowicz, Tomasz
    Hawranek, Michal
    Polonski, Lech
    Zembala, Marian
    JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (11) : 1277 - 1283
  • [46] The effect of renal insufficiency on clinical outcomes after coronary revascularization in patients with multivessel disease: The Arterial Revascularization Therapies Study (ARTS)
    Ix, JH
    Mercado, N
    Shlipak, MG
    Boersma, E
    Lemos, PA
    Lindenboom, W
    O'Neill, WW
    Wijns, W
    Serruys, PW
    CIRCULATION, 2002, 106 (19) : 492 - 492
  • [47] Complete Revascularization in Patients With STEMI and Multivessel Coronary Artery Disease: Is It Beneficial?
    Voudris, Konstantinos V.
    Feldman, Dmitriy N.
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2021, 23 (02)
  • [48] Surgical Versus Percutaneous Revascularization in Patients with Multivessel Coronary Artery Disease
    Piroze M. Davierwala
    Freidrich W. Mohr
    Current Atherosclerosis Reports, 2014, 16
  • [49] Debate on revascularization strategy for diabetic patients with multivessel coronary artery disease
    Dangas, G
    Moses, JW
    CIRCULATION, 2005, 112 (10) : 1507 - 1513
  • [50] Complete Revascularization in Patients With STEMI and Multivessel Coronary Artery Disease: Is It Beneficial?
    Konstantinos V. Voudris
    Dmitriy N. Feldman
    Current Treatment Options in Cardiovascular Medicine, 2021, 23 (2)